Chagas disease. The use of serology to establish drug efficacy. Value and limitations*

Authors

DOI:

https://doi.org/10.5216/rpt.v50i4.71556

Abstract

*Presented at the ”Consultative Meeting on the Strategic and Operational Aspects for the Clinical Development of Trypanocidal Drugs for Chagas Disease, 23-24 April 2007, Buenos Aires, Argentina.”, sponsored by TDR, WHO.

This publication is dedicated to one of the authors (deceased) due to his life dedicated to Chagas disease and particularly to this subject. After 14 years, this material is still valid.

Downloads

Download data is not yet available.

Downloads

Published

2022-01-17

Issue

Vol. 50 No. 4 (2021)

Section

SHORT REPORT

License

The manuscript submission must be accompanied by a letter signed by all authors stating the full name and email address, confirming that the material has not been published or is under consideration for publication elsewhere, and agreeing to transfer copyright in all media and formats for Journal of Tropical Pathology. The authors will not be paid for published articles. They are solely responsible for the content of those articles, even if the Editor holds the right to adjust them to the norms of the journal.

The reviewers will not be paid for the peer review process.

How to Cite

O. LUQUETTI, A.; RASSI**, A. Chagas disease. The use of serology to establish drug efficacy. Value and limitations*. Revista de Patologia Tropical / Journal of Tropical Pathology, v. 50, n. 4, p. 333–336, 17 Jan.2022.